These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6096758)

  • 1. Endogenous opioids modulate the effect of cholecystokinin on insulin release in dogs.
    Schusdziarra V; Lenz N; Rewes B; Pfeiffer EF
    Neuropeptides; 1984 Nov; 4(6):507-17. PubMed ID: 6096758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
    Schusdziarra V; Lenz N; Schick R; Maier V
    Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CCK on food intake in man: physiological or pharmacological effect?
    Schick RR; Schusdziarra V; Mössner J; Neuberger J; Schröder B; Segmüller R; Maier V; Classen M
    Z Gastroenterol; 1991 Feb; 29(2):53-8. PubMed ID: 1714670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of six cholecystokinin (CCK) fragments on insulin secretion in the mouse.
    Ahrén B; Hedner P; Lundquist I
    Acta Pharmacol Toxicol (Copenh); 1986 Feb; 58(2):115-20. PubMed ID: 3518338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans.
    Verspohl EJ; Ammon HP; Williams JA; Goldfine ID
    Diabetes; 1986 Jan; 35(1):38-43. PubMed ID: 3000856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
    Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
    Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition of amino acid infusions and effect of cholecystokinin on insulin release in dogs.
    Schmid R; Schusdziarra V; Butscher H; Classen M
    Clin Physiol Biochem; 1990; 8(5):244-9. PubMed ID: 2103898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of motilin-induced somatostatin release in dogs by naloxone.
    Schick R; Schusdziarra V
    Peptides; 1985; 6(5):861-4. PubMed ID: 2867525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans.
    Rushakoff RJ; Goldfine ID; Carter JD; Liddle RA
    J Clin Endocrinol Metab; 1987 Sep; 65(3):395-401. PubMed ID: 3305550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beta-casomorphins and analogs on insulin release in dogs.
    Schusdziarra V; Schick A; de la Fuente A; Specht J; Klier M; Brantl V; Pfeiffer EF
    Endocrinology; 1983 Mar; 112(3):885-9. PubMed ID: 6337048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro.
    Hermansen K
    Endocrinology; 1984 May; 114(5):1770-5. PubMed ID: 6143659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of C-terminal fragments of cholecystokinin on exocrine and endocrine secretion from isolated perfused rat pancreas.
    Okabayashi Y; Otsuki M; Ohki A; Sakamoto C; Baba S
    Endocrinology; 1983 Dec; 113(6):2210-15. PubMed ID: 6196184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Efendić S
    Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin (CCK)-4 and CCK-8 stimulate islet hormone secretion in vivo in the pig.
    Ahrén B; Mårtensson H; Nobin A
    Pancreas; 1988; 3(3):279-84. PubMed ID: 2898779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationship.
    Sandberg E; Ahrén B; Tendler D; Efendic S
    Pharmacol Toxicol; 1988 Jul; 63(1):42-5. PubMed ID: 3041399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulfation of CCK-8 on its stimulation of the endocrine and exocrine secretion from the isolated perfused porcine pancreas.
    Jensen SL; Holst JJ; Nielsen OV; Rehfeld JF
    Digestion; 1981; 22(6):305-9. PubMed ID: 6277714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of C-terminal fragments of cholecystokinin on plasma insulin and glucagon concentrations in sheep.
    Mineo H; Kamita H; Muto H; Ito M; Hyun HS; Onaga T; Yanaihara N
    Res Vet Sci; 1997; 62(2):171-4. PubMed ID: 9243718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naloxone on basal and stimulated insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Eur J Pharmacol; 1984 Jun; 102(1):135-9. PubMed ID: 6090153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.